Back

Discussant review - DUAL-ACS

31 August 2025 (09:19 - 09:24)
Organised by: Logo
Congress Presentation Part of: HOT LINE 6 Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Stefan James

Uppsala University, Uppsala (Sweden)

14 More presentations in this session

Presentation thumbnail
SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease
Professor M. Falkenberg (Gothenburg, SE)
Slides Video
Presentation thumbnail
Discussant review - SWEDEPAD 1 and 2
Professor M. Brodmann (Graz, AT)
Slides Video
Presentation thumbnail
Panel discussion - SWEDEPAD 1 and 2
Presentation thumbnail
The PULSE randomized controlled trial
Doctor O. De Filippo (Turin, IT)
Slides Video
Presentation thumbnail
Discussant review - PULSE
Doctor G. Stone (New York City, US)
Slides Video

Access the full session

Session thumbnail
HOT LINE 6
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 09:19 CET
You may be interested in
thumbnail
Congress Presentation
Following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months: pro
thumbnail
Congress Presentation
The DUAL-ACS Trial: Duration of DAPT in ACS
thumbnail
Congress Presentation
Should 12 months of dual antiplatelet therapy still be the default recommendation after primary PCI?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources